Senores Pharma to Incorporate Wholly Owned Subsidiary in Mexico
Senores Pharmaceuticals Limited announced its Board of Directors has approved the incorporation of a wholly-owned subsidiary in Mexico. This strategic move aims to support the company's business operations and growth objectives in the Mexican and broader international markets. The Board also approved the appointment of Mrs. Shilpa Sharma as Company Secretary and Compliance Officer, and Mr. Viranchi Arvindbhai Shah as an Additional Independent Director. Additionally, the Board approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), subject to shareholder and regulatory approvals. Key managerial personnel were authorized to determine materiality and make disclosures to stock exchanges.
Key Highlights
- Senores Pharma to establish a wholly-owned subsidiary in Mexico.
- Expansion aims to bolster presence in Mexican and international markets.
- New Company Secretary and Compliance Officer appointed.
- Additional Independent Director appointed to the Board.
- Employee Stock Option Scheme 2026 approved, pending approvals.
Price Impact
More from SENORES